Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered
Human content, AI powered search.

Latest Stories

ALERT: Dispensers advised to check Aripiprazole bottles for crystalline precipitate

Kiran Paul
By Kiran PaulMar 12, 2020
Kiran Paul
See Full Bio

Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Medicines Defect Information for Aripiprazole 1mg/ml Oral Solution by Mylan.

The regulator said Mylan UK has received a product complaint relating to crystalline precipitate being observed during bottle use.

The affected bathes are not being recalled to ensure continuity of supply of the anti-psychotic medicine, MHRA added.

Healthcare professionals are advised to visually inspect the product prior to administration and only use if the product is clear and free from crystalline precipitate.

The affected batches are:

Product: Aripiprazole 1mg/ml Oral Solution PL 04569/1667

Batch numberExpiry datePack sizeFirst distributed
05051930 April 2021150ml01 October 2019
04081931 July 2021150ml03 February 2020
07021931 January 2021150ml07 August 2019

Mylan can be contacted by emailing UKComplaints@mylan.co.uk if anyone receives units with the issue.

For more information or medical information enquiries, contact Mylan UK’s medical information department on +44(0) 1707 853000 or via email on Info.uk@mylan.co.uk.

mylan

Related News

Cervical cancer screening

Cervical cancer screening to be relaxed for those at low risk

Empowering the pharmacy workforce: A vital step towards a more efficient NHS
Guest Blog

Empowering the pharmacy workforce: A vital step towards a more efficient NHS

NHS for robotic surgery
News

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

Scotland's digital patient care record
News

Scotland's move to create digital patient care record hailed

More For You

A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less
Patients to get test results via NHS app

An investment of £50m has been made to upgrade the NHS app

Patients to get test results via NHS app

Millions of patients will now be able to access test results and get appointment reminders on their smartphones as the government tries to position the NHS app as the default mode of communication and steer away from traditional methods like letters.

An investment of £50m has been made to upgrade the NHS app and the health service hopes to save £200m over the next three years.

Keep ReadingShow less
Health minister assures House of Lords on measures to tackle UK-wide Creon drug shortage

Baroness Merron

Government taking steps to mitigate shortage of cancer drug Creon

Baroness Merron on Monday (9) assured the House of Lords that the government is taking measures to mitigate the shortage of pancreatic cancer drug Creon across the country.

Raising the issue, Baroness Margaret Ritchie wanted to know about the steps being taken by the government to ease the misery of patients suffering from pancreatic cancer.

Keep ReadingShow less
Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Janet Morrison

Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Community Pharmacy England (CPE) chief executive Janet Morrison has welcomed chancellor Rachel Reeves announcement today that day-to-day spending on the NHS will increase by £29bn a year but insisted that it must reflect in securing the future of pharmacy.

Reeves also revealed that the government will be increasing the NHS technology budget by almost 50 per cent, with £10bn of investment to "bring our analogue health system into the digital age, including through the NHS app".

Keep ReadingShow less
Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc